EE200300222A - 4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod - Google Patents

4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod

Info

Publication number: EE200300222A
Authority: EE; Estonia
Prior art keywords: sub; oximes; substituted; estra; benzaldehyde
Prior art date: 2000-11-10

Application number

EEP200300222A

Other languages

English (en)

Estonian (et)

Inventor

Schubert Gerd

Ring Sven

Erhart Bernd

Original Assignee

Schering Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-10

Filing date

2001-11-09

Publication date

2003-08-15

2001-11-09 Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft

2003-08-15 Publication of EE200300222A publication Critical patent/EE200300222A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Saccharide Compounds (AREA)
Epoxy Compounds (AREA)
Studio Devices (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

EEP200300222A 2000-11-10 2001-11-09 4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod EE200300222A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10056676A DE10056676A1 (de)	2000-11-10	2000-11-10	Verfahren zur Herstellung von 4-/17alpha-substituierten-3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E oder 1Z)-oximen
PCT/DE2001/004218 WO2002038582A2 (de)	2000-11-10	2001-11-09	Verfahren zur herstellung von 4-(17alpha-(substituierten-methyl)-3-oxoestra-4,9 dien-11-yl)benzaldehyd-(1e oder 1z)-oximen

Publications (1)

Publication Number	Publication Date
EE200300222A true EE200300222A (et)	2003-08-15

Family

ID=7663441

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300222A EE200300222A (et)	2000-11-10	2001-11-09	4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod

Country Status (25)

Country	Link
US (1)	US7214808B2 (xx)
EP (1)	EP1339734B1 (xx)
JP (1)	JP4263478B2 (xx)
KR (1)	KR100836323B1 (xx)
CN (1)	CN100368427C (xx)
AT (1)	ATE337328T1 (xx)
AU (2)	AU2002216911B2 (xx)
BG (1)	BG107886A (xx)
BR (1)	BR0115249A (xx)
CA (1)	CA2427632C (xx)
CZ (1)	CZ301425B6 (xx)
DE (2)	DE10056676A1 (xx)
EA (1)	EA005530B1 (xx)
EE (1)	EE200300222A (xx)
HR (1)	HRP20030458A2 (xx)
HU (1)	HUP0301765A2 (xx)
IL (2)	IL155680A0 (xx)
MX (1)	MXPA03004109A (xx)
NO (1)	NO20032080D0 (xx)
NZ (1)	NZ525962A (xx)
PL (1)	PL205091B1 (xx)
SK (1)	SK286601B6 (xx)
WO (1)	WO2002038582A2 (xx)
YU (1)	YU34303A (xx)
ZA (1)	ZA200304480B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006018888A1 (de) *	2006-04-18	2007-10-25	Bayer Schering Pharma Ag	Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
JP4843372B2 (ja) *	2006-05-09	2011-12-21	株式会社リコー	画像処理装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332283A1 (de) *	1993-09-20	1995-04-13	Jenapharm Gmbh	Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) *	1993-09-20	1997-05-28	Jenapharm Gmbh	11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5576310A (en) *	1994-09-20	1996-11-19	Jenapharm Gmbh	11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds

2000
- 2000-11-10 DE DE10056676A patent/DE10056676A1/de not_active Withdrawn
2001
- 2001-11-09 HU HU0301765A patent/HUP0301765A2/hu unknown
- 2001-11-09 CN CNB018186785A patent/CN100368427C/zh not_active Expired - Fee Related
- 2001-11-09 BR BR0115249-1A patent/BR0115249A/pt not_active IP Right Cessation
- 2001-11-09 EA EA200300506A patent/EA005530B1/ru not_active IP Right Cessation
- 2001-11-09 PL PL361399A patent/PL205091B1/pl not_active IP Right Cessation
- 2001-11-09 SK SK551-2003A patent/SK286601B6/sk not_active IP Right Cessation
- 2001-11-09 MX MXPA03004109A patent/MXPA03004109A/es active IP Right Grant
- 2001-11-09 WO PCT/DE2001/004218 patent/WO2002038582A2/de not_active Ceased
- 2001-11-09 IL IL15568001A patent/IL155680A0/xx unknown
- 2001-11-09 YU YU34303A patent/YU34303A/sh unknown
- 2001-11-09 JP JP2002541114A patent/JP4263478B2/ja not_active Expired - Fee Related
- 2001-11-09 DE DE50110829T patent/DE50110829D1/de not_active Expired - Lifetime
- 2001-11-09 AU AU2002216911A patent/AU2002216911B2/en not_active Ceased
- 2001-11-09 KR KR1020037006317A patent/KR100836323B1/ko not_active Expired - Fee Related
- 2001-11-09 CA CA2427632A patent/CA2427632C/en not_active Expired - Lifetime
- 2001-11-09 US US10/416,029 patent/US7214808B2/en not_active Expired - Lifetime
- 2001-11-09 AT AT01993608T patent/ATE337328T1/de not_active IP Right Cessation
- 2001-11-09 EE EEP200300222A patent/EE200300222A/xx unknown
- 2001-11-09 AU AU1691102A patent/AU1691102A/xx active Pending
- 2001-11-09 CZ CZ20031282A patent/CZ301425B6/cs not_active IP Right Cessation
- 2001-11-09 HR HR20030458A patent/HRP20030458A2/hr not_active Application Discontinuation
- 2001-11-09 EP EP01993608A patent/EP1339734B1/de not_active Expired - Lifetime
- 2001-11-09 NZ NZ525962A patent/NZ525962A/en unknown
2003
- 2003-04-30 IL IL155680A patent/IL155680A/en not_active IP Right Cessation
- 2003-05-09 NO NO20032080A patent/NO20032080D0/no unknown
- 2003-06-06 BG BG107886A patent/BG107886A/bg unknown
- 2003-06-09 ZA ZA200304480A patent/ZA200304480B/en unknown

Also Published As

Publication number	Publication date
NO20032080L (no)	2003-05-09
ATE337328T1 (de)	2006-09-15
AU2002216911B2 (en)	2007-06-14
NO20032080D0 (no)	2003-05-09
AU2002216911C1 (en)	2002-05-21
PL361399A1 (en)	2004-10-04
EP1339734B1 (de)	2006-08-23
US20040053905A1 (en)	2004-03-18
KR100836323B1 (ko)	2008-06-09
US7214808B2 (en)	2007-05-08
YU34303A (sh)	2006-08-17
CZ301425B6 (cs)	2010-02-24
CN100368427C (zh)	2008-02-13
DE10056676A1 (de)	2002-05-16
WO2002038582A3 (de)	2002-09-12
IL155680A0 (en)	2003-11-23
CZ20031282A3 (cs)	2003-08-13
JP2004513179A (ja)	2004-04-30
CA2427632C (en)	2010-01-26
CN1474829A (zh)	2004-02-11
BR0115249A (pt)	2003-08-12
EP1339734A2 (de)	2003-09-03
MXPA03004109A (es)	2004-07-08
CA2427632A1 (en)	2003-05-01
PL205091B1 (pl)	2010-03-31
EA005530B1 (ru)	2005-04-28
WO2002038582A2 (de)	2002-05-16
EA200300506A1 (ru)	2003-12-25
DE50110829D1 (de)	2006-10-05
SK5512003A3 (en)	2003-10-07
BG107886A (bg)	2004-02-27
SK286601B6 (sk)	2009-02-05
KR20030081330A (ko)	2003-10-17
NZ525962A (en)	2005-02-25
ZA200304480B (en)	2004-08-24
AU1691102A (en)	2002-05-21
IL155680A (en)	2009-06-15
HRP20030458A2 (en)	2005-04-30
HK1063187A1 (en)	2004-12-17
JP4263478B2 (ja)	2009-05-13
HUP0301765A2 (hu)	2003-09-29

Similar Documents

Publication	Publication Date	Title
NO932870D0 (no)	1993-08-12	Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
PT1257553E (pt)	2004-10-29	Derivados de pirrolopirimidinona, processo para a preparacao e uso
NO329883B1 (no)	2011-01-17	Fremgangsmate for fremstilling av prostaglandiner og analoger derav og av mellomforbindelser, og forbindelser fremstilt derved
NO20023189L (no)	2002-07-04	Fremgangsmåte for fremstilling av tolterodin og analoger derav samt intermediater fremstilt ved fremgangsmåten
DE60306667D1 (de)	2006-08-17	Cefdinir salze als zwischenprodukte
DK1127886T3 (da)	2003-09-01	Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
EA200200125A1 (ru)	2002-06-27	Способ получения амлодипина бензолсульфоната
ATE428693T1 (de)	2009-05-15	Prostaglandinsynthese
EE200300222A (et)	2003-08-15	4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod
WO2002024690A8 (en)	2002-08-08	Efficient process for the preparation of a factor xa inhibitor
EE200300090A (et)	2004-12-15	Asendatud imidasopüridiinühendite valmistamise meetod
NO20033049L (no)	2003-08-18	Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin
PT1250335E (pt)	2005-11-30	Processo e intermediarios para a preparacao de imidazopiridinas
DK0703237T3 (da)	2000-07-10	Fremgangsmåde til fremstilling af thio-phospholipider af ether-typen
DK1581504T3 (da)	2009-06-29	Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
DK1219625T3 (da)	2006-09-18	Hidtil ukendte substituerede 2-(6-benzyl-5-oxo-3-phenyl-(S3,7S,7AR)-perhydroimidazol-(1,5-C)(1,3) thiazol-7YL)forbindelser
NO20030605D0 (no)	2003-02-07	Fremgangsmåte for fremstilling av imidazo-(1,2-C)(2,3)- benzodiazepiner, samt mellomprodukter ved fremstillingen derav
AU2002216910A1 (en)	2002-05-21	Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes
DK61191A (da)	1991-04-05	Fremgangsmaade til fremstilling af 1alfa-silyloxy-4alfa-hydroxy-3beta-(3alfa-hydroxy-4-phenoxy-buten-1-yl)-cyclopent-2alfa-yl-alkynderivater
IT1318651B1 (it)	2003-08-27	Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.
DK1070082T3 (da)	2004-01-26	Fremgangsmåde til fremstilling af 4,4-dimethyl-5alfa-cholesta-8,14,24-trien-3beta-ol og mellemprodukter i fremgangsmåden (I)
NO20006527D0 (no)	2000-12-20	Forbedret fremgangsmåte for fremstilling av substituerte pyridinkarboksylsyrer
DK0675880T3 (da)	2000-04-17	Quinolondisulfider som mellemprodukter
EA200200741A1 (ru)	2002-12-26	Способ получения эфиров арилиминометилкарбаминовой кислоты